GlassScriptPhysician profile
Jonathann C Kuo
NPI 1992966469
$9,032.61
in general payments reported to CMS, 2019-2025
40 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,205 · 2020: $489 · 2021: $3,840 · 2022: $658 · 2023: $1,118 · 2024: $466 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170 · Travel and Lodging: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.72 |
| Travel and Lodging | $670.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $2,523.00 | 2021 | |
| Amgen INC. | $1,058.13 | 2019-2022 | |
| Biotissue Holdings INC. | $670.80 | 2023 | |
| Nevro Corp. | $592.23 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $489.09 | 2020-2025 | Relistor |
| Abbvie INC. | $413.06 | 2022-2025 | |
| Bioventus LLC | $377.44 | 2019-2025 | Durolane, Gelsyn-3, Xcell |
| Nalu Medical, INC. | $267.01 | 2021 | |
| Medtronic USA, INC. | $256.16 | 2019 | |
| Vertos Medical, INC. | $215.41 | 2019-2022 | |
| Allergan, INC. | $198.97 | 2019-2021 | |
| Medtronic, INC. | $179.95 | 2022-2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $146.81 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $139.53 | 2024 | Infuse |
| Pacira Therapeutics, INC. | $136.26 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathann Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.